SORT1 rs12744310: LDL Cholesterol and Heart Risk
The rs12744310 single nucleotide polymorphism is a noncoding regulatory variant located in the chromosome 1p13.3 locus near the SORT1 gene. Genome-wide association studies link variation at this locus to changes in liver sortilin expression, circulating low-density lipoprotein (LDL) cholesterol levels, and relative risk of myocardial infarction. While carrying particular alleles is statistically associated with cardiovascular risk profiles, it functions as a predisposition marker rather than a direct clinical diagnosis.
What each genotype means
Baseline cholesterol risk profile
This genotype is associated with baseline levels of SORT1 expression in the liver. Research indicates that individuals with this genotype do not carry the specific allele linked to increased hepatic SORT1 levels and the associated rise in LDL cholesterol. This is considered the common or reference state in many populations.
This is the most common genotype in many populations, though frequencies vary significantly by ancestry.
Intermediate cholesterol risk profile
Carrying one copy of the T allele is associated with altered regulation of the SORT1 gene in the liver. Studies suggest this may lead to moderate changes in LDL cholesterol levels and a corresponding shift in cardiovascular risk compared to those without the T allele. You should discuss your lipid profile and cardiovascular health with your clinician.
This heterozygous genotype is found in a significant portion of the population, particularly in individuals of European ancestry.
Elevated cholesterol risk profile
This genotype is associated with increased hepatic expression of the SORT1 gene, which has been linked in genome-wide association studies to higher levels of LDL cholesterol. Elevated LDL cholesterol is a known risk factor for atherosclerosis and myocardial infarction. Please consult with your healthcare provider to review your cholesterol levels and overall cardiovascular risk management.
This genotype is less common than the CC or CT genotypes, with a frequency reflecting the minor allele frequency of approximately 0.20 in European populations.
Genomic Location and the 1p13.3 Regulatory Region
The rs12744310 polymorphism resides on the short arm of chromosome 1 at band 1p13.3, a dense genomic region harboring several functionally related genes, including SORT1, CELSR2, and PSRC1. Rather than altering a protein's amino acid sequence, rs12744310 sits within a noncoding regulatory sequence. Large-scale mapping studies, such as functional investigations into the 1p13 cholesterol locus, demonstrate that variants in this region exist in strong linkage disequilibrium with regulatory changes that modify transcription factor binding—most notably affecting hepatic enhancer activity. Because of this position in an active liver regulatory domain, variations here influence how robustly nearby transcripts are produced, serving as an expression quantitative trait locus (eQTL) for the liver rather than disrupting structural protein integrity.
SORT1 and Hepatic Lipoprotein Export
The SORT1 gene encodes sortilin 1, a multi-ligand type I sorting receptor primarily involved in the intracellular trafficking and sorting of proteins between the Golgi apparatus, endosomes, and the cell membrane. In hepatocytes, sortilin plays an essential role in lipid metabolism by interacting directly with apolipoprotein B100 (apoB100). Through this interaction, sortilin modulates the intracellular assembly, retention, and secretion of very low-density lipoprotein (VLDL) particles, the precursors to circulating LDL particles. Additionally, sortilin participates in the cellular clearance of circulating lipoproteins and trafficking of PCSK9. Variations that affect hepatic SORT1 transcription consequently shift the balance of lipoprotein secretion and catabolism, altering circulating total cholesterol and LDL cholesterol levels in the bloodstream.
Research Associations and Cardiovascular Predisposition
Multiple genome-wide association studies (GWAS) have repeatedly pinpointed the 1p13.3 locus as one of the strongest common genetic determinants of circulating LDL cholesterol and early-onset myocardial infarction in human populations. Research shows that alleles conferring increased hepatic SORT1 expression are associated with lower circulating LDL-C and a reduced risk of coronary heart disease, whereas alternative alleles are associated with elevated LDL-C and an increased predisposition to myocardial infarction. While the statistical evidence linking the 1p13 locus to cardiovascular endpoints is robust across cohorts, catalog evidence specifically isolating rs12744310 remains classified as limited because high regional linkage disequilibrium makes it challenging to disentangle the independent effect of rs12744310 from neighboring functional markers like rs12740374.
Population Patterns and Ancestry-Specific Linkage
The distribution of alleles across 1p13.3 shows substantial variation across ancestral populations. In European cohorts, the minor allele frequency hovers around 0.20 to 0.30, where strong linkage disequilibrium blocks commonly link rs12744310 with adjacent regulatory single nucleotide polymorphisms. In contrast, in populations of African ancestry, the minor allele frequency is noticeably lower, estimated at approximately 0.08. Because the architecture of linkage disequilibrium is shorter and more fragmented in diverse African genomes, the statistical tag provided by rs12744310 does not always correlate identically with functional enhancers across all ancestries, underscoring the importance of considering ancestral genetic context when interpreting locus-level risk.
Understanding What Genetic Predisposition Means for You
Carrying an allele associated with altered LDL cholesterol does not mean a person will inevitably develop cardiovascular disease, nor does a protective allele guarantee immunity from heart attacks. Polygenic background, smoking status, dietary habits, physical activity, blood pressure, and metabolic health interact continuously with individual genetic variants. Consumers should view rs12744310 information as an educational insight into their baseline biological tendencies, not as a diagnostic test. Individuals interested in their cardiovascular health should undergo standard clinical lipid panel testing and discuss comprehensive prevention strategies or lipid-lowering therapies directly with a qualified healthcare provider.
How common is this variant?
The minor allele frequency for rs12744310 is estimated at approximately 0.20 in European ancestries and about 0.08 in African ancestries, with varying degrees of linkage disequilibrium across different global populations.
Frequently asked questions
Does having the rs12744310 variant mean I have high cholesterol?
No. Genetic variants at the SORT1 locus represent statistical predispositions rather than absolute outcomes. Actual circulating cholesterol levels are determined by clinical blood tests and are influenced by numerous other genes, diet, exercise, and overall lifestyle.
Can I use rs12744310 to decide if I need statins?
No, this genetic test cannot be used to start, stop, or adjust prescription medications. Clinical decisions regarding statin therapy or other lipid-lowering treatments depend on measured lipid panels, overall cardiovascular risk scores, and consultations with your physician.
Why is the evidence strength for this variant listed as limited?
Although the 1p13.3 chromosomal locus is strongly tied to LDL cholesterol, rs12744310 is one of several neighboring markers in high linkage disequilibrium. Pinpointing whether rs12744310 directly causes the biological change or is simply tagging an adjacent causal variant remains an active area of study.
How does the SORT1 gene affect heart attack risk?
SORT1 encodes sortilin, a cellular receptor that regulates how the liver packages and exports apolipoprotein B-containing particles like VLDL and LDL into the bloodstream. Altered sortilin expression changes circulating LDL levels, which over time influences the buildup of arterial plaque and the long-term risk of myocardial infarction.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12744310?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SORT1
Variant in SORT1 significantly associated with LDL cholesterol levels and coronary artery disease risk.
A regulatory variant at the 1p13 locus near SORT1/CELSR2 that strongly influences LDL-C levels and coronary artery disease risk.
Functional regulatory variant at the 1p13 locus that alters hepatic SORT1 expression, modulating plasma LDL-C levels and coronary artery disease risk.
This variant influences LDL cholesterol levels and is a significant marker for cardiovascular health.
This SNP is linked to variations in LDL cholesterol levels and risk of coronary artery disease.